Features

A leading researcher in applying DNA sequencing to diagnostics will present the Robert W. Schrier, MD, Endowed Lectureship on Friday, Nov. 8. Ali G. Gharavi, MD, will speak on “Diagnostic Exome Sequencing in Chronic Kidney Disease (CKD).”

Ali G. Gharavi, MD

The author of the bestseller What Patients Say; What Doctors Hear will give a talk on that subject at a plenary on Sunday, Nov. 10. The book explores how refocusing the conversations between doctors and patients can lead to improved health outcomes.

Danielle Ofri, MD, PhD

...

They say a brand should be revisited every 10 years. ASN last rebranded in 2008 and since then, the society has gone through drastic changes. Membership has increased by 138%. ASN added two publications (ASN Kidney News and e-newsletter In the Loop) as well as launched a new self-assessment program (KSAP).

The Belding H. Scribner Award will be tendered to Paul L. Kimmel, MD, on Sunday, Nov. 10, for his career-long contributions to the practice of nephrology. Dr. Kimmel is program manager of the Kidney Precision Medicine Project and director of the HIV Kidney Program at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in Bethesda, Md.

For nearly 20 years, the field of diabetic kidney disease (DKD) was essentially stalled without impactful therapeutic advances. However, that landscape has dramatically changed with the recent discovery of kidney and cardiovascular benefits from SGLT2 inhibitors and GLP-1 receptor agonists.

Patients with kidney disease have disordered bone and mineral metabolism, including elevated serum concentrations of fibroblast growth factor-23 (FGF23). These elevated concentrations are associated with cardiovascular and all-cause mortality, which will be the subject of the Jack W. Coburn, MD, Endowed Lectureship, on Thursday, Nov. 7.

Pages